Innate Pharma S.A. ADS - ADR Financials

$1.95

$-0.10 (-4.88%)

As on 09-Sep-2026 16:00EDT

Market cap

$232 Mln

Revenue (TTM)

$66 Mln

P/E Ratio

--

P/B Ratio

20.1

Div. Yield

0 %

Annual
Quarterly

Income Statement (€ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	2.79	12.62	51.90	57.67	12.11	69.77
Cost of Revenue	--	51.98	56.02	51.66	47.00	49.71
Gross Profit	2.79	12.62	5.62	6.01	-22.30	20.07
Operating Expenses	56.21	64.20	18.29	63.44	25.52	18.99
Operating Profit (EBIT)	-53.43	-51.58	-12.67	-57.43	-47.83	1.08
Other Income	--	--	--	--	--	--
Profit before Tax	-49.18	-49.47	-7.57	-57.97	-45.48	-0.83
Provision for Tax	-5.96	--	-9.73	41.13	13.66	6.76
Profit after Tax (Net Income)	-49.18	-49.47	-7.57	-58.10	-52.81	-63.98
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-58.10	-52.81	-63.98

Liabilities (€ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	-21.69	8.83	51.90	54.15	107.44	155.98
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	47.75	69.24	83.65	112.37	80.17	104.75
Current Liabilities	36.63	32.98	39.64	41.34	79.89	45.49
Total Liabilities	62.69	111.06	175.19	207.86	267.50	307.42

Assets (€ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	16.00	25.32	27.18	68.03	129.24	134.09
Current Assets	46.69	85.74	148.01	139.83	138.26	173.33
Total Assets	62.69	111.06	184.19	207.86	267.50	307.42
Total Debt*	22.56	31.00	39.89	42.25	44.25	19.09
Net Current Assets	10.06	52.76	108.38	98.49	58.37	126.64

Cashflow (€ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	-32.56	-6.90	-32.56	-19.15	-58.46	-51.81
Cash Flow from Investing Activities	20.63	9.20	20.63	1.88	-0.92	-13.37
Cash from Financing Activities	-1.97	-6.01	-1.97	-1.83	26.82	-1.14
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS (€)	-0.54	-0.61	-0.09	-0.72	-0.66	-0.81
Cash EPS (€)	-0.48	-0.59	-0.03	-0.16	-0.61	-0.09
Adjusted Book Value (€)	--	0.11	0.64	0.68	1.35	1.98
Dividend per Share (€)	--	--	--	--	--	--
Cash Flow per Share (€)	-0.36	-0.09	-0.40	-0.24	-0.73	-0.66
Free Cash Flow per Share (€)	-0.38	-0.09	-0.43	-0.25	-0.75	-0.80

Profitability Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	-241.67	-75.17	-8.04	-46.84	-32.32	-31.12
ROE (%)	764.76	-162.91	-14.28	-71.91	-40.10	-34.27
ROA (%)	-56.61	-34.57	-3.95	-24.45	-18.37	-18.05
EBIT Margin (%)	-1,748.73	-387.49	-13.35	-100.02	-394.86	1.55
Net Margin (%)	-1,764.51	-391.97	-14.59	-100.74	-436.01	-91.70
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-0.78	-0.76	-0.10	3.76	-0.83	0.01
EBIT Growth (%)	0.34	-605.70	87.99	-20.61	-4,532.34	102.89
Net Profit Growth (%)	0.59	-553.51	86.97	-10.02	17.47	-208.22
EPS Growth (%)	0.12	-5.51	0.87	-0.09	0.18	-1.57
Book Value Growth (%)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	-1.04	3.51	0.77	0.78	0.41	0.12
Short term debt to equity ratio	-0.41	0.99	0.17	0.04	0.29	0.01
Current Ratio	1.27	2.60	3.73	3.38	1.73	3.81
Quick Ratio	--	--	3.82	3.38	1.79	3.74
Interest Coverage	-110.77	-86.40	-10.83	-200.29	-153.29	3.16

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	273.05	13.02	89.57	5.45	13.71	16.23
Asset Turnover	0.03	0.09	0.27	0.24	0.04	0.20
Receivable days	606.33	696.47	174.63	15.20	195.80	37.02
Inventory Days	--	-23.71	-11.01	-17.49	-6.47	32.63
Payable days	--	57.91	72.42	100.34	137.77	178.80
Cash Conversion Cycle	--	614.84	91.20	-102.63	51.57	-109.15